Bacillus Calmette-Guerin (BCG) Vaccine Market

The global Bacillus Calmette-Guerin (BCG) vaccine market size was valued at USD 61.84 billion in 2024 and is expected to reach USD 92.06 billion by 2032, at a CAGR of 5.10% during the forecast period The market growth is primarily driven by the ongoing global efforts to control tuberculosis (TB), particularly in high-burden countries, along with increased immunization programs supported by government and international agencies In addition, the resurgence of interest in BCG vaccines for non-specific immune benefits—such as protection against other infections and potential uses in bladder cancer treatment—is contributing to broader market demand. These expanding applications and renewed global health focus are expected to propel steady market growth https://www.databridgemarketresearch.com/reports/global-bacillus-calmette-guerin-bcg-vaccine-market